Telehealth Is Here to Stay: But How Do You Find the Right Markets?
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics. There’s no denying the importance of technology in healthcare; in fact, it became even…
This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.
Promoted content from I Don't Care on MarketScale.
Free workspace
Turn your Healthcare expertise into content.
Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.
The challenges healthcare executives and administrators face are constantly changing. Host Kevin Stevenson talks with the heroes behind the heroes that are enabling hospitals, urgent care centers and telemedicine operators to spend their time tending to patients, while they handle the logistics.
There’s no denying the importance of technology in healthcare; in fact, it became even more critical in the last year. With so many opportunities to improve care delivery, it’s about getting the right products to market. That’s the focus on Aaron Call, Founder of Jaunt. He joined I Don’t Care and host Kevin Stevenson to talk about this dynamic. Call is a long-time med-tech startup pioneer. Jaunt connects businesses with investors through data-backed insights and models.
“We work on early-stage companies and focusing on what can be improved for healthcare and then how to commercialize,” Call explained.
“It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.” – Aaron Call
While telehealth is certainly the buzziest tech in the space, it’s not the only field Jaunt specializes in, but Call and his team worked with telemed platforms differentiate.
“Years ago, we saw that most companies were just SaaS products, not much different than Zoom. We helped a client realize there was a need for much more robust tools for such a system,” Call noted.
Call also noted the U.S. had little adoption pre-pandemic. “It amazed me. There were so many economic benefits. It was the payers holding it up in many ways, and the pandemic adjusted this.”
Jaunt realized that what they were doing for companies with market analysis and commercialization strategies was what investors were seeking in due diligence. “We’re serving up information from a third party that startups can use to go to investors, and the investors know us as a trusted source.”
Call said that the pandemic didn’t dry up investment, as they first expected. What it did do is change approaches to commercialization, sales models, and predictive market analytics.
He also shared what’s exciting him in the space right now. “Personalized health with data and tech behind it is exciting. Digital health that can help change behaviors and improve life is also big right now.”
Follow us on social media for the latest updates in B2B!
Twitter – @MarketScale
Facebook – facebook.com/marketscale
LinkedIn – linkedin.com/company/marketscale
Part of this channel
I Don't Care
Candid healthcare leadership conversations with Kevin Stevenson
Your experts belong here
Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.
Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.
